Vaxart, Inc. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
Vaxart, Inc. (VXRT) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $31.79 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-06.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2021-02-25
- Vaxart, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2018-12-31 was $0.00.
- Vaxart, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2018-09-30 was $0.00.
- Vaxart, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2018 was $31.79M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $0.00 derived: sum of 2 quarters · filed 2019-02-06 | $31.79M 10-K · filed 2019-02-06 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $31.79M 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | $31.79M 10-Q · filed 2018-08-10 | ||||
| 2018-02-13 | $31.79M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |